Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis

被引：14

作者：

Kumar V.L. ^{[1
]}

Guruprasad B. ^{[1
]}

Wahane V.D. ^{[1
]}

机构：

[1] Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar

来源：

Inflammopharmacology | 2010年 / 18卷 / 6期

关键词：

Atorvastatin; Inflammation; Monoarthritis; Oxidative stress;

D O I：

10.1007/s10787-010-0057-1

中图分类号：

学科分类号：

摘要：

Arthritis is a joint disorder where the joint damage is associated with elevated levels of inflammatory mediators and reactive oxygen species (ROS). The inflammatory hyperalgesia associated with arthritis has been shown to be attenuated by anti-hyperlipidemic drug, atorvastatin. The present study was carried out to evaluate the effect of atorvastatin on joint inflammation and associated oxidative stress markers in a rat model where arthritis was induced by inra-articular injection of 0.1 ml of 0.1% Freund's Complete Adjuvant (FCA). Atorvastatin (10 mg and 50 mg/kg) and diclofenac (5 mg/kg) were administered orally, daily during the study period of 4 days and their effect on joint inflammation was evaluated by measuring joint diameter, levels of glutathione (GSH), thiobarbituric acid reactive substances (TBARS), activity of super oxide dismutase (SOD) and tissue histology. Atorvastatin produced a dose-dependent reduction in joint inflammation that was associated with normalization of levels of oxidative stress markers and tissue histology and its effect was found to be comparable to that of diclofenac. © 2010 Springer Basel AG.

引用

页码：303 / 308

页数：5

共 34 条

[1]

Abramson S.B., Attur M., Amin A.R., Clancy R., Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis, Curr Rheumatol Rep, 3, pp. 535-541, (2001)

[2]

Adam O., Laufs U., Antioxidative effects of statins, Arch Toxicol, 82, pp. 885-892, (2008)

[3]

Barsante M.M., Roffe E., Yokoro C.M., Tafuri W.L., Souza D.G., Pinho V., Castro M.S.D.A., Teixeira M.M., Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis, European Journal of Pharmacology, 516, 3, pp. 282-289, (2005)

[4]

Blum A., Shamburek R., The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis, Atherosclerosis, 203, pp. 325-330, (2009)

[5]

Bradford M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, pp. 248-254, (1976)

[6]

Butler S.H., Godefroy F., Besson J.M., Weil-Fugazza J., A limited arthritic model for chronic pain studies in the rat, Pain, 48, pp. 73-81, (1992)

[7]

Cerhan J.R., Saag K.G., Merlino L.A., Mikuls T.R., Criswell L.A., Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women, American Journal of Epidemiology, 157, 4, pp. 345-354, (2003)

[8]

Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto Jr. A.M., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS, Journal of the American Medical Association, 279, 20, pp. 1615-1622, (1998)

[9]

Ellman G.L., Tissue sulfhydryl groups, Arch Biochem Biophys, 82, pp. 70-77, (1959)

[10]

Funk J.L., Chen J., Downey K.J., Clark R.A., Bone protective effect of simvastatin in experimental arthritis, J Rheumatol, 35, pp. 1083-1091, (2008)

← 1 2 3 4 →